PHARMADANICA A/S: Financial statements 2026
CVR: 19056007
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2026. In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385. The solvency ratio was 99.9%.
- Profit/Loss
- DKK 4,314,032
- Equity
- DKK 20,960,385
- Total Assets
- DKK 20,990,385
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | - | 4.3M | 21M | - |
| 2025 | - | - | -340K | 16.6M | - |
| 2024 | - | - | -15K | 17.5M | - |
| 2023 | - | - | -1.1M | 17.5M | - |
| 2022 | - | - | 476K | 18.6M | - |
Official annual report
Find more companies like PHARMADANICA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Contact info changed: new phone: 48163200, new email: [email protected] (October 21, 2026).
Contact info changed: new phone: 48163200, new email: [email protected] (September 28, 2026).
As of September 24, 2026, Jean-Marc Pierre Rene Leccia has joined the board of directors of PHARMADANICA A/S.
As of September 24, 2026, Eric Pierre Jean Muris has joined the board of directors of PHARMADANICA A/S.
As of September 24, 2026, Jean-Marc Pierre Rene Leccia is registered as adm. dir. of PHARMADANICA A/S.
As of September 24, 2026, Nicolai Buhl Andersen has stepped down as adm. dir. of PHARMADANICA A/S.
As of September 23, 2026, Jean-Marc Pierre Rene Leccia has left the board of directors of PHARMADANICA A/S.
As of September 23, 2026, Eric Pierre Jean Muris has left the board of directors of PHARMADANICA A/S.
Contact info changed: new phone: 48163200, new email: [email protected] (September 7, 2026).
As of September 1, 2026, Nicolai Buhl Andersen is registered as adm. dir. of PHARMADANICA A/S.
About PHARMADANICA A/S
PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.